Amar M. Kamat

Founder and CEO, Sencilia B.V.

Amar M. Kamat is listed as Founder and CEO, Sencilia B.V.. Amar is scheduled to speak at MEDICA 2026 on 16 November 2026.

Compiled from published conference agendas; not yet confirmed by Amar. Is this you? Claim this profile.

About

Dr. Amar M. Kamat is Founder and CEO of Sencilia, an early-stage Dutch MedTech startup developing non-contact sensor technology for safer and more precise IV infusion therapy. He holds a PhD in Engineering Science and Mechanics from Penn State University and has published 30+ peer-reviewed scientific articles in sensor technology, bioinspired engineering, and medical device innovation. His work focuses on translating advanced sensing research into clinical solutions for vulnerable patients.

Upcoming

MEDICA 2026 16 November 2026 – 19 November 2026

Sencilia - Rely-V: Closing the blind spot in low-flow infusion therapy Speaker · 16 November 2026
Redefining precision in critical infusion therapy: Rely-V® non-contact low-flow sensors Speaker · 17 November 2026